are excreted in the urine in unchanged form, with the remainder as hydroxylated is often self-administered by nasal inhalation, intravenous injection and free-base 1. One Step Drug of Abuse Test and deaminated derivatives. smoking. It is excreted in the urine in a short time primarily as Benzoylecgonine.2 The AMP 1000 assay contained within the One Step Drug of Abuse Test yields a positive result Benzoylecgonine, a major metabolite of cocaine, has a longer biological half-life (5-8 hours) than (Strip, Dipcard, Cassette, Cup) 2 when Amphetamines in urine exceed 1,000 ng/mL. This is the suggested screening cut-off for cocaine (0.5-1.5 hours), and can generally be detected for 24-48 hours after cocaine exposure. positive specimens set by the Substance Abuse and Mental Health Services Administration The COC 300 assay contained within the One Step Drug of Abuse Test yields a positive result Package Insert for Multi Drug Screen Test (SAMHSA, USA). 3 when the cocaine metabolite in urine exceeds 300 ng/mL. This is the suggested screening cut-off

for positive specimens set by the Substance Abuse and Mental Health Services Administration This Instruction Sheet is for testing of any combination of the following drugs: (AMP 500) (SAMHSA, USA).3 AMP/BAR/BZO/BUP/COC/THC/MTD/mAMP/MDMA/MOR/OPI/OXY/PCP/PPX/TCA/EDDP/6-ACM/ACL See AMPHETAMINE (AMP 1000) for the summary. Including Adulterant Tests (Specimen Validity Tests) for: The AMP 500 assay contained within the One Step Drug of Abuse Test yields a positive result COCAINE (COC 150) Oxidants (OX), Specific Gravity (S.G), pH, Creatinine (CRE), Nitrite (NIT) and Glutaraldehyde (GLU). when Amphetamines in urine exceeds 500 ng/mL. See COCAINE (COC 300) for the summary. A rapid, one step screening test for the simultaneous, qualitative detection of multiple drugs and drug The COC 150 assay contained within the One Step Drug of Abuse Test yields a positive result metabolites in human urine. For Forensic Use Only. AMPHETAMINE (AMP 300) when the concentration of Benzoylecgonine in urine exceeds 150 ng/mL. See AMPHETAMINE (AMP 1000) for the summary. INTENDED USE The AMP 300 assay contained within the One Step Drug of Abuse Test yields a positive result MARIJUANA (THC 50) when Amphetamines in urine exceeds 300 ng/mL. THC (∆9-tetrahydrocannabinol) is the primary active ingredient in cannabis (marijuana). When smoked or orally administered, THC produces euphoric effects. Users have impaired short term The One Step Drug of Abuse Test is a lateral flow chromatographic immunoassay for the qualitative detection BARBITURATES (BAR) memory and slowed learning. They may also experience transient episodes of confusion and of multiple drugs and drug metabolites in urine at the following cut-off concentrations: Barbiturates are central nervous system depressants. They are used therapeutically as sedatives, anxiety. Long-term, relatively heavy use may be associated with behavioral disorders. The peak Test Calibrator Cut-off hypnotics, and anticonvulsants. Barbiturates are almost always taken orally as capsules or tablets. effect of marijuana administered by smoking occurs in 20-30 minutes and the duration is 90-120 Amphetamine (AMP 1000) D-Amphetamine 1,000 ng/mL The effects resemble those of intoxication with alcohol. Chronic use of barbiturates leads to minutes after one cigarette. Elevated levels of urinary metabolites are found within hours of

Amphetamine (AMP 500) D-Amphetamine 500 ng/mL tolerance and physical dependence. Short acting Barbiturates taken at 400 mg/day for 2-3 months exposure and remain detectable for 3-10 days after smoking. The main metabolite excreted in the can produce a clinically significant degree of physical dependence. Withdrawal symptoms urine is 11-nor- 9-tetrahydrocannabinol-9-carboxylic acid ( 9-THC-COOH). Amphetamine (AMP 300) D-Amphetamine 300 ng/mL ∆ ∆ experienced during periods of drug abstinence can be severe enough to cause death. Only a The THC 50 assay contained within the One Step Drug of Abuse Test yields a positive result when Barbiturates (BAR) Secobarbital 300 ng/mL 9 small amount (less than 5%) of most Barbiturates are excreted unaltered in the urine. the concentration of ∆ -THC-COOH in urine exceeds 50 ng/mL. This is the suggested screening Benzodiazepines (BZO) Oxazepam 300 ng/mL The approximate detection time limits for Barbiturates are: cut-off for positive specimens set by the Substance Abuse and Mental Health Services Buprenorphine (BUP) Buprenorphine 10 ng/mL Short acting (e.g. Secobarbital) 100 mg PO (oral) 4.5 days Administration (SAMHSA, USA).3 4 Cocaine (COC 300) Benzoylecgonine 300 ng/mL Long acting (e.g. Phenobarbital) 400 mg PO (oral) 7 days Cocaine (COC 150) Benzoylecgonine 150 ng/mL The BAR assay contained within the One Step Drug of Abuse Test yields a positive result when the MARIJUANA (THC 20) Barbiturates in urine exceed 300 ng/mL. See MARIJUANA (THC 50) for the summary. Marijuana (THC 50) 11-nor-∆9-THC-9-COOH 50 ng/mL The THC 20 assay contained within the One Step Drug of Abuse Test yields a positive result when 9 Marijuana (THC 20) 11-nor- -THC-9-COOH 20 ng/mL 9 ∆ BENZODIAZEPINES (BZO) the concentration of ∆ -THC-COOH in urine exceeds 20 ng/mL. Methadone (MTD) Methadone 300 ng/mL Benzodiazepines are medications that are frequently prescribed for the symptomatic treatment of (mAMP 1000) D-Methamphetamine 1,000 ng/mL anxiety and sleep disorders. They produce their effects via specific receptors involving a METHADONE (MTD) Methamphetamine (mAMP 500) D-Methamphetamine 500 ng/mL neurochemical called gamma aminobutyric acid (GABA). Because they are safer and more Methadone is a narcotic analgesic prescribed for the management of moderate to severe pain and Methylenedioxymethamphetamine (MDMA) D,L-Methylenedioxymethamphetamine 500 ng/mL effective, Benzodiazepines have replaced barbiturates in the treatment of both anxiety and for the treatment of opiate dependence (heroin, Vicodin, Percocet, Morphine). The pharmacology insomnia. Benzodiazepines are also used as sedatives before some surgical and medical of oral Methadone is very different from IV Methadone. Oral Methadone is partially stored in the Opiate 300 (OPI 300, MOP, MOR) Morphine 300 ng/mL procedures, and for the treatment of seizure disorders and alcohol withdrawal. liver for later use. IV Methadone acts more like heroin. In most states you must go to a pain clinic Opiate 2000 (OPI 2000) Morphine 2,000 ng/mL Risk of physical dependence increases if Benzodiazepines are taken regularly (e.g., daily) for or a Methadone maintenance clinic to be prescribed Methadone. Methadone is a long acting pain Oxycodone (OXY) Oxycodone 100 ng/mL more than a few months, especially at higher than normal doses. Stopping abruptly can bring on reliever producing effects that last from twelve to forty-eight hours. Ideally, Methadone frees the (PCP) Phencyclidine 25 ng/mL such symptoms as trouble sleeping, gastrointestinal upset, feeling unwell, loss of appetite, client from the pressures of obtaining illegal heroin, from the dangers of injection, and from the Propoxyphene (PPX) Propoxyphene 300 ng/mL sweating, trembling, weakness, anxiety and changes in perception. emotional roller coaster that most opiates produce. Methadone, if taken for long periods and at Tricyclic (TCA) Nortriptyline 1,000 ng/mL Only trace amounts (less than 1%) of most Benzodiazepines are excreted unaltered in the urine; large doses, can lead to a very long withdrawal period. The withdrawals from Methadone are more most of the concentration in urine is conjugated drug. The detection period for the prolonged and troublesome than those provoked by heroin cessation, yet the substitution and 2-Ethylidene-1,5-dimethyl-3,3-dipheylpyrrolidine (EDDP) 2-Ethylidene-1,5-dimethyl-3,3-dipheylpyrrolidine 300 ng/mL Benzodiazepines in the urine is 3-7 days. phased removal of methadone is an acceptable method of detoxification for patients and 6-Acetylmorphine (6-ACM) 6-Acetylmorphine 10 ng/mL The BZO assay contained within the One Step Drug of Abuse Test yields a positive result when therapists.4 Alcohol (ACL) Alcohol >0.04% the Benzodiazepines in urine exceed 300 ng/mL. The MTD assay contained within the One Step Drug of Abuse Test yields a positive result when the Methadone in urine exceeds 300 ng/mL. This assay provides only a preliminary qualitative test result. Use a more specific alternate quantitative analytical BUPRENORPHINE (BUP) method to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred 1 Buprenorphine is a semisynthetic opioid analgesic derived from thebain, a component of opium. It METHAMPHETAMINE (mAMP 1000) confirmatory method. Apply clinical and professional judgment to any drug of abuse test result, particularly when has a longer duration of action than morphine when indicated for the treatment of moderate to Methamphetamine is an addictive drug that strongly activates certain systems in the preliminary positive results are obtained. severe pain, perioperative analgesia, and opioid dependence. Low doses buprenorphine produces brain. Methamphetamine is closely related chemically to amphetamine, but the central nervous SUMMARY AND EXPLANATION OF THE TEST sufficient agonist effect to enable opioid addicted individuals to discontinue the misuse of opioids system effects of Methamphetamine are greater. Methamphetamine is made in illegal laboratories without experiencing withdrawal symptoms. Buprenorphine carries a lower risk of abuse, and has a high potential for abuse and dependence. The drug can be taken orally, injected, or addiction, and side effects compared to full opioid agonists because of the “ceiling effect”, which inhaled. Acute higher doses lead to enhanced stimulation of the central nervous system and The One Step Drug of Abuse Test is a competitive immunoassay utilizing highly specific reactions means no longer continue to increase with further increases in dose when reaching a plateau at induce euphoria, alertness, reduced appetite, and a sense of increased energy and power. between antibodies and antigens for the detection of multiple drugs and drug metabolites in human urine moderate doses. However, it has also been shown that Buprenorphine has abuse potential and Cardiovascular responses to Methamphetamine include increased blood pressure and cardiac without the use of an instrument. may itself cause dependency. Subutex®, and a Buprenorphine/Naloxone combination product, arrhythmias. More acute responses produce anxiety, paranoia, hallucinations, psychotic behavior, Suboxone®, are the only two forms of Buprenorphine that have been approved by FDA in 2002 for and eventually, depression and exhaustion. The effects of Methamphetamine generally last 2-4 AMPHETAMINE (AMP 1000) use in opioid addiction treatment. Buprenorphine was rescheduled from Schedule V to Schedule hours and the drug has a half-life of 9-24 hours in the body. Methamphetamine is excreted in the Amphetamine is a Schedule II controlled substance available by prescription (Dexedrine®) and is III drug just before FDA approval of Suboxone and Subutex. urine as amphetamine and oxidized and delaminated derivatives. However, 10-20% of also available on the illicit market. Amphetamines are a class of potent sympathomimetic agents The BUP assay contained within the One Step Drug of Abuse Test yields a positive result when the Methamphetamine is excreted unchanged. Thus, the presence of the parent compound in the with therapeutic applications. They are chemically related to the human body's natural Buprenorphine in urine exceeds 10 ng/mL. urine indicates Methamphetamine use. Methamphetamine is generally detectable in the urine for P N : : epinephrine and . Acute higher doses lead to enhanced 3-5 days, depending on urine pH level. stimulation of the central nervous system and induce euphoria, alertness, reduced appetite, and a Y 0 3 1 COCAINE (COC 300) The mAMP 1000 assay contained within the One Step Drug of Abuse Test yields a positive result sense of increased energy and power. Cardiovascular responses to Amphetamines include Cocaine is a potent central nervous system (CNS) stimulant and a local anesthetic. Initially, it when the Methamphetamine in urine exceeds 1,000 ng/mL. 1

1 increased blood pressure and cardiac arrhythmias. More acute responses produce anxiety,

1 0 7 3 brings about extreme energy and restlessness while gradually resulting in tremors, over-sensitivity paranoia, hallucinations, and psychotic behavior. The effects of Amphetamines generally last 2-4 and spasms. In large amounts, cocaine causes fever, unresponsiveness, difficulty in breathing and hours following use, and the drug has a half-life of 4-24 hours in the body. About 30% of unconsciousness. METHAMPHETAMINE (mAMP 500) PCP can be found in urine within 4 to 6 hours after use and will remain in urine for 7 to 14 days, ADULTERANT TESTS (SPECIMEN VALIDITY TESTS) SUMMARY See METHAMPHETAMINE (mAMP 1000) for the summary. depending on factors such as metabolic rate, user's age, weight, activity, and diet.5 Phencyclidine is The mAMP 500 assay contained within the One Step Drug of Abuse Test yields a positive result excreted in the urine as an unchanged drug (4% to 19%) and conjugated metabolites (25% to 30%).6 The adulterant test strip contains chemically treated reagent pads. Observation of the color when the concentration of Methamphetamine in urine exceeds 500 ng/mL. The PCP assay contained within the One Step Drug of Abuse Test yields a positive result when the change on the strip compared to the color chart provides a semi-quantitative screen for oxidants, phencyclidine level in urine exceeds 25 ng/mL. This is the suggested screening cut-off for positive specific gravity, pH, creatinine, nitrite and glutaraldehyde in human urine which can help to assess METHYLENEDIOXYMETHAMPHETAMINE (MDMA) specimens set by the Substance Abuse and Mental Health Services Administration (SAMHSA, the integrity of the urine specimen. Methylenedioxymethamphetamine (ecstasy) is a designer drug first synthesized in 1914 by a USA). 3 German drug company for the treatment of obesity.8 Those who take the drug frequently report ADULTERATION adverse effects, such as increased muscle tension and sweating. MDMA is not clearly a stimulant, PROPOXYPHENE (PPX) although it has, in common with amphetamine drugs, a capacity to increase blood pressure and Propoxyphene is a mild narcotic analgesic found in various pharmaceutical preparations, usually Adulteration is the tampering of a urine specimen with the intention of altering the test results. The heart rate. MDMA does produce some perceptual changes in the form of increased sensitivity to as the hydrochloride or napsylate salt. These preparations typically also contain large amounts of use of adulterants in the urine specimen can cause false negative results by either interfering with light, difficulty in focusing, and blurred vision in some users. Its mechanism of action is thought to acetaminophen, aspirin, or . Peak plasma concentrations of propoxyphene are achieved the test and/or destroying the drugs present in the urine. Dilution may also be used to produce be via release of the serotonin. MDMA may also release , although the from 1 to 2 hours post dose. In the case of overdose, propoxyphene blood concentrations can false negative drug test results. To determine certain urinary characteristics such as specific general opinion is that this is a secondary effect of the drug (Nichols and Oberlender, 1990). The reach significantly higher levels. In human, propoxyphene is metabolized by N-demethylation to gravity and pH, and to detect the presence of oxidants, nitrite, glutaraldehyde and creatinine in most pervasive effect of MDMA, occurring in virtually all people who took a reasonable dose of the yield norpropoxyphene. Norpropoxyphene has a longer half-life (30 to 36 hours) than parent urine are considered to be the best ways to test for adulteration or dilution. drug, was to produce a clenching of the jaws. propoxyphene (6 to 12 hours). The accumulation of norpropoxyphene seen with repeated doses The MDMA assay contained within the One Step Drug of Abuse Test yields a positive result when may be largely responsible for resultant toxicity. • Oxidants (OX): Tests for the presence of oxidizing agents such as bleach and peroxide in the urine. the Methylenedioxymethamphetamine in urine exceeds 500 ng/mL. The PPX assay contained within the One Step Drug of Abuse Test yields a positive result when the • Specific Gravity (S.G.): Tests for sample dilution. Normal levels for specific gravity will range concentration of Propoxyphene or Norpropoxyphene in urine exceeds 300 ng/mL. from 1.003 to 1.030. Specific gravity levels of less than 1.003 or higher than 1.030 may be an OPIATE (OPI 300, MOR, MOP) indication of adulteration or specimen dilution. Opiate refers to any drug that is derived from the opium poppy, including the natural products, TRICYCLIC ANTIDEPRESSANTS (TCA) • pH: Tests for the presence of acidic or alkaline adulterants in urine. Normal pH levels should be in the morphine and codeine, and the semisynthetic drugs such as heroin. Opioid is more general, Tricyclic Antidepressants (TCA) are commonly used for the treatment of depressive disorders. range of 4.0 to 9.0. Values below pH 4.0 or above pH 9.0 may indicate the sample has been altered. referring to any drug that acts on the opioid receptor. TCA overdoses can result in profound central nervous system depression, cardiotoxicity and • Nitrite (NIT): Tests for commercial adulterants such as Klear and Whizzies. Normal urine Opioid analgesics comprise a large group of substances which control pain by depressing the anticholinergic effects. TCA overdose is the most common cause of death from prescription drugs. specimens should contain no trace of nitrite. Positive results for nitrite usually indicate the central nervous system. Large doses of morphine can produce higher tolerance levels, TCAs are taken orally or sometimes by injection. TCAs are metabolized in the liver. Both TCAs presence of an adulterant. physiological dependency in users, and may lead to substance abuse. Morphine is excreted and their metabolites are excreted in urine mostly in the form of metabolites for up to ten days. • Glutaraldehyde (GLU): Tests for the presence of an aldehyde. Glutaraldehyde is not normally unmetabolized, and is also the major metabolic product of codeine and heroin. Morphine is The TCA assay contained within the One Step Drug of Abuse Test yields a positive result when the found in a urine specimen. Detection of glutaraldehyde in a specimen is generally an indicator detectable in the urine for several days after an opiate dose.4 concentration of Tricyclic Antidepressants in urine exceeds 1,000 ng/mL. of adulteration. The OPI 300 assay contained within the One Step Drug of Abuse Test yields a positive result when • Creatinine (CRE): Creatinine is one way to check for dilution and flushing, which are the most the concentration of opiate exceeds the 300 ng/mL cut-off level. 2-ETHYLIDENE-1,5-DIMETHYL-3,3-DIPHEYLPYRROLIDINE (EDDP) common mechanisms used in an attempt to circumvent drug testing. Low creatinine may EDDP is an immunoassay based on the principle of competitive binding. Drugs which may be indicate dilute urine. OPIATE 2000 (OPI 2000) present in the urine specimen compete against the drug conjugate for binding sites on the Opiate refers to any drug that is derived from the opium poppy, including the natural products, antibody. PRINCIPLE morphine and codeine, and the semisynthetic drugs such as heroin. Opioid is more general, During testing, a urine specimen migrates upward by capillary action. EDDP, if present in the urine referring to any drug that acts on the opioid receptor. specimen below 300 ng/mL, will not saturate the binding sites of antibody coated particles in the (1) The One Step Drug of Abuse Test is an immunoassay based on the principle of competitive Opioid analgesics comprise a large group of substances which control pain by depressing the test device. The antibody-coated particles will then be captured by immobilized EDDP conjugate binding. Drugs which may be present in the urine specimen compete against their respective drug central nervous system. Large doses of morphine can produce higher tolerance levels, and a visible colored line will show up in the test line region. The colored line will not form in the conjugate for binding sites on their specific antibody. physiological dependency in users, and may lead to substance abuse. Morphine is excreted test line region if the EDDP level exceeds 300 ng/mL because it will saturate all the binding sites During testing, a urine specimen migrates upward by capillary action. A drug, if present in the urine unmetabolized, and is also the major metabolic product of codeine and heroin. Morphine is of anti-EDDP antibodies. A drug-positive urine specimen will not generate a colored line in the test specimen below its cut-off concentration, will not saturate the binding sites of its specific antibody. detectable in the urine for several days after an opiate dose.3 line region, while a drug-negative urine specimen or a specimen containing a drug concentration The antibody will then react with the drug-protein conjugate and a visible colored line will show up The OPI 2000 assay contained within the One Step Drug of Abuse Test yields a positive result when the less than the cut-off will generate a line in the test line region. To serve as a procedural control, a in the test line region of the speci f i c drug strip. The presence of drug above the cut-off morphine in urine exceeds 2,000 ng/mL. This is the suggested screening cut-off for positive specimens colored line will always appear at the control line region indicating that proper volume of specimen concentration will saturate all the binding sites of the antibody. Therefore, the colored line will not set by the Substance Abuse and Mental Health Services Administration (SAMHSA, USA). 3 has been added and membrane wicking has occurred. form in the test line region. The EDDP assay contained within the One Step Drug of Abuse Test yields a positive result when A drug-positive urine specimen will not generate a colored line in the specific test line region of the OXYCODONE (OXY) 2-Ethylidene-1,5-Dimethyl-3,3-Dipheylpyrrolidine in urine exceeds 300 ng/mL. strip because of drug competition, while a drug-negative urine specimen will generate a line in the O x y c o d o n e , [ 4 , 5 - e p o x y - 1 4 - h y d r o x y - 3 - m e t h o x y - 1 7 - m e t h y l - m o r p h i n a n - 6 - o n e , test line region because of the absence of drug competition. dihydrohydroxycodeinone] is a semisynthetic opioid agonist derived from thebaine, a constituent 6-ACETYLMORPHINE (6-ACM) To serve as a procedural control, a colored line will always appear at the control line region, of opium. Oxycodone is a Schedule II narcotic analgesic and is widely used in clinical medicine. 6-Acetylmorphine (6-ACM) is one of three active metabolites of heroin (diacetylmorphine), the indicating that proper volume of specimen has been added and membrane wicking has occurred. The pharmacology of oxycodone is similar to that of morphine, in all respects, including its abuse others being morphine and the much less active 3-acetylmorphine (3-ACM). 6-ACM is rapidly and dependence liabilities. Pharmacological effects include analgesia, euphoria, feelings of created from heroin in the body, and then is either metabolized into morphine or excreted in the (2) Alcohol test is based on the high specifity of alcohol oxidase (ALOx) for ethyl alcohol in the relaxation, respiratory depression, constipation, papillary constriction, and cough suppression. urine. Since 6-ACM is a unique metabolite to heroin, its presence in the urine confirms that heroin presence of peroxidase and enzyme substrate such as tetramethylbenzidine (TMB) as shown in Oxycodone is prescribed for the relief of moderate to high pain under pharmaceutical trade names was the opioid used. This is significant because on a urine immunoassay drug screen, the test the following: as OxyContin® (controlled release), OxyIR®, OxyFast® (immediate release formulations), or typically tests for morphine, which is a metabolite of a number of legal and illegal opiates/opioids ALOX/Peroxidase Percodan® (aspirin) and Percocet® (acetaminophen) that are in combination with other such as codeine, morphine sulphate, and heroin. 6-ACM remains in the urine for no more than 24 EtOH + TMB CH3CHO + Colored TMB nonnarcotic analgesics. Oxycodone's behavioral effects can last up to 5 hours. The controlled- hours so a urine specimen must be collected soon after the last heroin use, but the presence of 6- release product, OxyContin®, has a longer duration of action (8-12 hours). ACM guarantees that heroin was in fact used as recently as within the last day. The distinct color on reactive pad could be observed in less than 60 seconds after the reaction pad The OXY assay contained within the One Step Drug of Abuse Test yields a positive result when the The 6-ACM assay contained within the One Step Drug of Abuse Test yields a positive result when was wetted with urine specimens with the ethyl alcohol concentration greater than 0.04%. It should Oxycodone in urine exceeds 100 ng/mL. 6-Acetylmorphine in urine exceeds 10 ng/mL. be pointed out that other alcohols such as methyl, propanyl and allyl alcohol would develop the similar color on the reactive pad. However, these alcohols are not normally present in human urine. PHENCYCLIDINE (PCP) ALCOHOL (ACL) Phencyclidine, also known as PCP or Angel Dust, is a hallucinogen that was first marketed as a Excess or inappropriate consumption of alcohol is a common and pervasive social problem. It is a REAGENTS surgical anesthetic in the 1950's. It was removed from the market because patients receiving it contributory factor to many accidents, injuries and medical conditions. Urine alcohol test is became delirious and experienced hallucinations. intended for use as a rapid method to detect the presence of alcohol in urine greater than (1) The test contains a membrane strip coated with drug-protein conjugates (purified bovine Phencyclidine is used in powder, capsule, and tablet form. The powder is either snorted or smoked 0.04%.To confirm the concentration of positive specimens, an alternate, non-enzymatic technology albumin) on the test line, a goat polyclonal antibody against gold-protein conjugate at the control after mixing it with marijuana or vegetable matter. Phencyclidine is most commonly administered such as headspace gas chromatography should be used. line, and a dye pad which contains colloidal gold particles coated with mouse monoclonal antibody by inhalation but can be used intravenously, intra-nasally, and orally. After low doses, the user specific to individual drug on the list in the "Intended Use" section. thinks and acts swiftly and experiences mood swings from euphoria to depression. Self-injurious (2) The alcohol pad contains tetramethylbenzidine, alcohol oxidaze, peroxidase, buffer and behavior is one of the devastating effects of phencyclidine. stabilizing proteins. [For Dipcard] ADULTERANT TESTS (SPECIMEN VALIDITY TESTS) REAGENTS 1) Remove the test device from the foil pouch. QUALITY CONTROL 2) Remove the cap from the test device. Label the device with patient or control identifications. Adulteration Pad Reactive Indicator Buffers and Non-reactive Ingredients 3) Immerse the absorbent tip into the urine sample for 5 seconds. Urine sample should not touch the plastic device. Oxidants (OX) 0.36% 99.64% 4) Replace the cap over the absorbent tip and lay the device flatly on a non-absorptive clean surface. A procedural control is included in the test. A color line appearing in the control region (C) is Specific Gravity (S.G.) 0.25% 99.75% 5) Read results of alcohol test at 2 minutes, adulterant tests at 3 minutes, and drug tests at 5 minutes. DO considered an internal procedural control. It confirms sufficient specimen volume, adequate pH 0.06% 99.94% NOT READ ALCOHOL AND ADULTERANT TESTS RESULTS AFTER 5 MINUTES AND DRUG TESTS membrane wicking and correct procedural technique. Nitrite (NIT) 0.07% 99.93% RESULTS AFTER 10 MINUTES. (Fig. 3) Glutaraldehyde (GLU) 0.02% 99.98% LIMITATIONS Creatinine (CRE) 0.04% 99.96% 1. The One Step Drug of Abuse Test provides only a qualitative, preliminary analytical result. A PRECAUTIONS secondary analytical method must be used to obtain a confirmed result. Gas (Fig. 3) chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. 3,4,7 • For Forensic Use Only. [For Multi-Drug Screen Test Cup] 2. There is a possibility that technical or procedural errors, as well as other interfering • Do not use after the expiration date. Please follow the instructions on the Procedure Card. Read results of alcohol test at 2 minutes, adulterant test at 3 minutes, and drug tests at 5 minutes. DO NOT READ ALCOHOL AND ADULTERANT TESTS substances in the urine specimen may cause erroneous results. • The test device should remain in the sealed pouch until use. RESULTS AFTER 5 MINUTES AND DRUG TESTS RESULTS AFTER 10 MINUTES. (Fig. 4) 3. Adulterants, such as bleach and/or alum, in urine specimens may produce erroneous results • The test is for single use. regardless of the analytical method used. If adulteration is suspected, the test should be • While urine is not classified by OSHA or the CDC as a biological hazard unless visibly contaminated ID： repeated with another urine specimen and a new test device. 8,9 DATE： C (-) (+) with blood , the use of gloves is recommended to avoid unnecessary contact with the specimen. T NEGATIVE POSITIVE INVALID m M 4. A positive result does not indicate intoxication of the donor, the concentration of drug in the C A T O O M A H P D C P M C I M • The used test device and urine specimen should be discarded according to federal, state and local P A C C C C C urine, or the route of drug administration. regulations. T T T T T 5. A negative result may not necessarily indicate drug-free urine. Negative results can be (Fig. 4) NEGATIVE POSITIVE INVALID obtained when drug is present but below the cut-off level of the test. STORAGE AND STABILITY 6. Test does not distinguish between drugs of abuse and certain medications. INTERPRETATION OF RESULTS 7. A positive test result may be obtained from certain foods or food supplements. Store as packaged in the sealed pouch at 2-30oC (36-86oF). The test is stable through the 8. Alcohol test is designed for use with human urine only. A positive result indicates only the expiration date printed on the sealed pouch. The test device must remain in the sealed pouch until (Please refer to the previous illustration) presence of alcohol and does not indicate or measure intoxication. use. DO NOT FREEZE. Do not use beyond the expiration date. NEGATIVE: Two lines appear. * One color line should be in the control region (C), and another 9. There is a possibility that technical or procedure error for alcohol test as well other apparent color line adjacent should be in the test region (T). This negative result indicates that the substances in certain foods and medicines may interfere with the test and cause false SPECIMEN COLLECTION AND PREPARATION drug concentration is below the detectable level. results. Please refer to “Analytical Specificity” section for alcohol test list of substances that *NOTE: The shade of color in the test line region (T) will vary, but it should be considered negative Urine Assay will interfere the test results. The urine specimen must be collected in a clean and dry container. Urine collected at any time of the day may whenever there is even a faint distinguishable color line. 10.Alcohol test is a semi-quantitative assay. It identifies alcohol in human urine specimens at a be used. Urine specimens exhibiting visible precipitates should be allowed to settle to obtain a clear specimen POSITIVE: One color line appears in the control region (C). No line appears in the test region (T). concentration of 0.04% or higher. for testing. This positive result indicates that the drug concentration is above the detectable level. INVALID: Control line fails to appear. Insufficient specimen volume or incorrect procedural PERFORMANCE CHARACTERISTICS SPECIMEN STORAGE techniques are the most likely reasons for control line failure. Review the procedure and repeat the test using a new test device. If the problem persists, discontinue using the lot immediately and Accuracy Urine specimens may be stored at 2-8°C (36-46°F) for up to 48 hours prior to testing. For prolonged contact your supplier. In the comparison study, the One Step Drug of Abuse Test was compared to a GC/MS reference storage, specimens may be frozen and stored below -20°C. Frozen specimens should be thawed and mixed well before testing. method to determine its accuracy. Clinical urine samples were collected for each of the drug (Please refer to the alcohol color chart) types list on the following table. Clinical specimens were quantified by GC/MS analysis before MATERIALS Alcohol Test Results testing. NEGATIVE: Almost no color change by comparing with the background. The negative result Test Compounds Contributed to the Totals of GC/MS indicates that the alcohol concentration is less than 0.04%. Materials Provided AMP Amphetamine POSITIVE: A distinct color developed all over the pad. The positive result indicates that the urine • Test device • Desiccants • Package insert • Procedure card (for test cup use only) BAR Secobarbital, Butalbital, Phenobarbital, Pentobarbital alcohol concentration is 0.04% or higher. • Color chart card for adulterant and alcohol interpretation (when applicable) BZO Oxazepam, Nordiazepam, α -OH-Alprazolam, Desalkylflurazepam INVALID: The test should be considered invalid if only the edge of the reactive pad turned color • Disposable specimen droppers (for test cassette only) BUP Buprenorphine that might be attributed to insufficient sampling. The subject should be retested. COC Benzoylecgonine Materials Required But Not Provided 9 • Specimen collection container (for strip, cassette, dipcard) • Disposable gloves • Timer THC 11-nor-∆ -tetrahydrocannabinol-9-carboxylic acid ADULTERANT TESTS (SPECIMEN VALIDITY TESTS) INTERPRETATION MTD Methadone DIRECTIONS FOR USE mAMP Methamphetamine (Please refer to the color chart) MDMA D,L-Methylenedioxymethamphetamine, Methylenedioxyamphetamine Morphine, Codeine Allow the test device, and urine specimen to come to room temperature [15-30°C (59-86°F)] prior to testing. Semi-quantitative results are obtained by visually comparing the reacted color blocks on the strip OPI, MOP [For Strip] to the printed color indicator on the color chart. No instrumentation is required. OXY Oxycodone 1) Remove the strip from the foil wrapper or the desiccated container (bring the container to the room PCP Phencyclidine temperature before opening to avoid condensation of moisture in container). Label the strip with patient ADULTERANT TESTS (SPECIMEN VALIDITY TESTS) LIMITATIONS PPX Propoxyphene or control identifications. TCA Nortriptyline 2) Immerse the strip into the urine with the arrow end pointing toward the urine. Do not cover the urine 2-Ethylidene-1,5-Dimethyl-3,3-Dipheylpyrrolidine over the MAX (maximum) line. You may leave the strip in the urine or you may take the strip out after a 1. The adulterant tests included with the product are meant to aid in the determination of abnormal EDDP minimum of 15 seconds in the urine and lay the strip flatly on a non-absorptive clean surface. specimens, but may not cover all the possible adulterants. 6-ACM 6-Acetylmorphine 3) Read results at 5 minutes. DO NOT READ RESULT AFTER 10 MINUTES. (Fig. 1) 2. Oxidants: Normal human urine should not contain oxidants. The presence of high level of antioxidants in The following results are tabulated from these clinical studies: the specimen, such as ascorbic acid, may result in false negative results for the oxidants pad. [For Cassette] % Agreement with GC/MS (HPLC for TCA) 1) Remove the test device from its foil wrapper by tearing along the slice (bring the container to the room 3. Specific Gravity: Elevated levels of protein in urine may cause abnormally high specific gravity values. A M P mAMP OPI 2000 OPI 300 COC PCP AMP300 COC150 THC20 mAMP500 6-ACM temperature before opening to avoid condensation of moisture in container). Label the device with 4. Nitrite: Nitrite is not a normal component of human urine. However, nitrite found in urine may Positive Agreement 95% 96% >99% 96% 96% 95% >99% >99% >99% >99% patient or control identifications. indicate urinary tract infections or bacterial infections. Nitrite levels of > 20mg/dL may produce 98% Negative 2) Using the specimen dropper, withdraw the urine sample from the specimen container and slowly dispense 3 false positive glutaraldehyde results. Agreement >99% >99% 97% >99% >99% >99% 98% >99% >99% >99% >99% drops (approximately 120 L) into the circular sample well, being careful not to overfill the absorbent pad. P N : µ 5. Glutaraldehyde: Is not normally found in a urine specimen. However certain metabolic Overall 3) Read results of alcohol test at 2 minutes, and drug tests at 5 minutes. DO NOT READ ALCOHOL TEST 98% 98% 98% 98% 98% 95% 99% >99% >99% >99% 99% abnormalities such as ketoacidosis (fasting, uncontrolled diabetes or high-protein diets) may Agreement Y 0 3 1 RESULT AFTER 5 MINUTES AND DRUG TESTS RESULTS AFTER 10 MINUTES. (Fig. 2) BAR TCA MDMA BZO MTD OXY EDDP THC PPX BUP AMP500 interfere with the test results. Positive

1 Agreement 97% 98% 93% 96% 94% 95% 98% 96% 95% 93% >99%

1 6. Creatinine: Tests for the specimen for dilution and flushing. Normal creatinine levels are between 1 0 7 3 20 and 350mg/dL. Under rare conditions, certain kidney diseases may show dilute urine. Negative Agreement 98% >99% >99% >99% 98% >99% 95% >99% 98% 95% 95% Overall MAX Agreement 98% 99% 96% 98% 96% 98% 96% 98% 96% 94% 98% (Fig. 1) (Fig. 2) BAR MDMA BZO MTD OXY TCA THC BENZODIAZEPINES (BZO) Analyte METHAMPHETAMINE (mAMP 1000) Pos Neg Pos Neg Pos Neg Pos Neg Pos Neg Pos Neg Pos Neg Negative Samples 0 4 0 4 0 5 0 3 0 4 0 4 0 0 Oxazepam Total number of Result Precision Methamphetamine Total number of Result Precision Near Cut-off Negative conc.(ng/mL) Determinations Samples [ between 50% 1 37 0 36 0 28 1 44 0 36 0 36 0 15 conc.(ng/mL) Determinations of cut-off and cut-off ] Near Cut-off Positive No drug present 40 40 negative >99% No drug present 40 40 negative >99% Samples [ between cut- 34 1 33 3 27 2 27 2 34 2 35 1 23 1 off and 150% of cut-off ] 150 40 40 negative >99% 500 40 40 negative >99% Positive Samples [>150% of cut-off ] 3 0 4 0 18 0 3 0 4 0 4 0 1 0 225 40 40 negative >99% 750 40 40 negative >99% Agreement with GC/MS 97% 98% 93% >99% 96% >99% 94% 98% 95% >99% 98% >99% 96% >99% 300 40 40 positive >99% 1,000 40 40 positive >99% PCP THC20 AMP300 mAMP OPI300 OPI2000 COC Analyte 450 40 40 positive >99% Pos Neg Pos Neg Pos Neg Pos Neg Pos Neg Pos Neg Pos Neg 1,500 40 40 positive >99% Negative Samples 0 1 0 40 0 42 0 4 0 3 0 17 0 0 Near Cut-off Negative Samples [ between 50% 0 0 0 3 1 6 0 10 0 11 1 13 0 13 COCAINE (COC 300) of cut-off and cut-off ] METHAMPHETAMINE (mAMP 500) Near Cut-off Positive Benzoylecgonine Total number of Result Precision Samples [ between cut- 7 2 3 0 3 0 3 1 18 1 3 0 26 1 conc.(ng/mL) Determinations off and 150% of cut-off ] Methamphetamine Total number of Result Precision Positive Samples conc.(ng/mL) [>150% of cut-off ] 28 0 47 0 40 0 22 0 7 0 6 0 0 0 No drug present 40 40 negative >99% Determinations Agreement with GC/MS 95% >99% >99% >99% >99% 98% 96% >99% 96% >99% >99% 97% 96% >99% 150 40 40 negative >99% No drug present 60 60 negative >99% AMP PPX EDDP BUP COC150 mAMP 500 AMP500 6-ACM

Analyte Pos Neg Pos Neg Pos Neg Pos Neg Pos Neg Pos Neg Pos Neg Pos Neg 225 40 40 negative >99% 250 30 30 negative >99% Negative Samples 0 0 0 20 0 20 0 20 0 40 0 42 0 20 0 20 375 40 40 positive >99% 375 15 15 negative >99% Near Cut-off Negative Samples [ between 50% 0 19 1 19 2 18 2 18 0 6 0 6 2 18 0 20 450 40 40 positive >99% 625 15 12 positive >80% of cut-off and cut-off ] Near Cut-off Positive 750 30 30 positive >99% Samples [ between cut- 7 1 18 2 19 1 17 3 4 0 1 1 0 20 0 19 1 off and 150% of cut-off ] COCAINE (COC 150) 1000 30 30 positive >99% Positive Samples 13 0 31 0 20 0 20 0 [>150% of cut-off ] 20 0 20 0 20 0 51 0 Benzoylecgonine Total number of Result Precision Agreement with GC/MS 95% >99% 95% 98% 98% 95% 93% 95% >99% >99% >99% 99% >99% 95% 98% >99% conc.(ng/mL) Determinations METHYLENEDIOXYMETHAMPHETAMINE (MDMA) No drug present 60 60 negative >99% Reproducibility 75 30 30 negative >99% Methylenedioxymeth- Total number of Result Precision Reproducibility studies were carried out using commercially available stock solutions of the drug amphetamine Determinations analytes listed. Dilutions were made from the stock solution of each drug to the concentrations 112.5 15 15 negative >99% conc.(ng/mL) specified in the following tables. The results are listed in the following tables. 187.5 15 11 positive >73% No drug present 40 40 negative >99% 225 30 29 positive >96% 250 40 40 negative >99% AMPHETAMINE (AMP 1000) 300 30 30 positive >99% 375 40 40 negative >99% Amphetamine Total number of Result Precision 500 40 40 positive >99% conc.(ng/mL) Determinations MARIJUANA (THC 50) 750 40 40 positive >99%

No drug present 40 40 negative >99% 11-nor-∆9-THC-9-COOH Total number of Result Precision OPIATE 300 (OPI 300, MOP, MOR) 500 40 40 negative >99% conc.(ng/mL) Determinations 750 40 40 negative >99% No drug present 40 40 negative >99% Morphine Total number of Result Precision conc.(ng/mL) Determinations 1,000 40 40 positive >99% 25 40 40 negative >99% 1,500 40 40 positive >99% 37.5 40 40 negative >99% No drug present 40 40 negative >99% 50 40 40 positive >99% 150 40 40 negative >99% AMPHETAMINE (AMP 500) 75 40 40 positive >99% 225 40 40 negative >99% 300 40 40 positive >99% Amphetamine Total number of Result Precision conc.(ng/mL) Determinations MARIJUANA (THC 20) 375 40 40 positive >99%

No drug present 9 40 40 negative >99% 11-nor-∆ -THC-9-COOH Total number of Result Precision OPIATE 2000 (OPI 2000) 250 40 40 negative >99% conc.(ng/mL) Determinations 750 Morphine Total number of Result Precision 40 40 positive >99% No drug present 60 60 negative >99% conc.(ng/mL) Determinations 1,000 40 40 positive >99% 10 30 29 negative 97% No drug present 40 40 negative >99% 15 15 9 negative 60% 1,000 40 40 negative >99% AMPHETAMINE (AMP 300) 25 15 12 positive >80% 1,500 40 40 negative >99% Amphetamine Total number of Result Precision 30 30 29 positive 97% 2,000 40 40 positive >99% conc.(ng/mL) Determinations 40 30 30 positive >99% 3,000 40 40 positive >99% No drug present 60 60 negative >99% 150 30 30 negative >99% METHADONE (MTD) OXYCODONE (OXY) 225 15 15 negative >99% Methadone Total number of Result Precision 375 15 15 positive >99% Oxycodone Total number of Result Precision conc.(ng/mL) Determinations conc.(ng/mL) Determinations 450 30 30 positive >99% No drug present 40 40 negative >99% 600 30 30 positive >99% No drug present 40 40 negative >99% 150 40 40 negative >99% 50 40 40 negative >99% BARBITURATES (BAR) 225 40 40 negative >99% 75 40 40 negative >99% 300 40 40 positive >99% Secobarbital Total number of Result Precision 100 40 40 positive >99% conc.(ng/mL) Determinations 450 40 40 positive >99% 150 40 40 positive >99% No drug present 40 40 negative >99% 150 40 40 negative >99% 225 40 40 negative >99% 300 40 40 positive >99% 450 40 40 positive >99% PHENCYCLIDINE (PCP) Alphenol 150 Phencyclidine Total number of Result Precision Drug concentration n MTD m AMP1000 MDMA MOP OPI 2000 OXY PCP TCA conc.(ng/mL) Determinations Cut-off Range - + - + - + - + - + - + - + - + Aprobarbital 200 Butabarbital 75 No drug present 40 40 negative >99% 0% Cut-off 10 10 0 10 0 10 0 10 0 10 0 10 0 10 0 10 0 Butalbital 2,500 12.5 40 40 negative >99% 10 0 10 0 10 0 -50% Cut-off 10 10 0 10 0 10 0 10 0 10 0 Butethal 19 40 40 negative >99% 100 -25% Cut-off 10 10 0 10 0 10 0 10 0 10 0 10 0 10 0 10 0 Cyclopentobarbital 25 40 40 positive >99% 600 Cut-off 10 0 10 0 10 0 10 0 10 0 10 0 10 0 10 0 10 Pentobarbital 37.5 40 40 positive >99% 300 +25% Cut-off 10 0 10 0 10 0 10 0 10 0 10 0 10 0 10 0 10 Phenobarbital 100 TRICYCLIC ANTIDEPRESSANTS (TCA) +50% Cut-off 10 0 10 0 10 0 10 0 10 0 10 0 10 0 10 0 10 BENZODIAZEPINES (BZO) Nortiptyline Total number of Result Precision conc.(ng/mL) Determinations a-Hydroxyalprazolam 1,260 Drug concentration AMP 300 COC 150 THC 20 mAMP 500 n Alprazalam 200 No drug present 40 40 negative >99% Cut-off Range - + - + - + - + 500 40 40 negative >99% Bromazepam 1,560 0% Cut-off 25 25 0 25 0 0 25 25 0 750 40 40 negative >99% Chlordiazepoxide 1,565 -50% Cut-off 25 25 0 25 0 0 25 25 0 1,000 40 40 positive >99% Chlordiazepoxide HCl 780 1,500 40 40 positive >99% -25% Cut-off 25 25 0 25 0 25 0 25 0 Clobazam 100 Cut-off 25 1 24 3 22 2 23 2 23 Clonazepam 785 2-ETHYLIDENE-1,5-DIMETHYL-3,3-DIPHEYLPYRROLIDINE (EDDP) +25% Cut-off 25 0 25 0 25 0 25 0 25 Clorazepate Dipotassium 195 Delorazepam EDDP Total number of Result Precision +50% Cut-off 25 0 25 0 25 0 25 0 25 1,560 conc.(ng/mL) Determinations Desalkylflurazepam 390 Diazepam 195 No drug present 60 60 negative >99% Drug concentration BUP PPX EDDP 6-ACM AMP500 n Estazolam 2,500 150 60 60 negative >99% Cut-off Range - + - + - + - + - + 450 60 60 positive >99% Flunitrazepam 385 0% Cut-off 90 90 0 90 0 90 0 90 0 90 0 600 60 60 positive >99% (±) Lorazepam 1,560 -50% Cut-off 90 0 90 0 90 0 90 0 90 90 0 RS-Lorazepam glucuronide 160 6-ACETYLMORPHINE (6-ACM) -25% Cut-off 90 81 9 81 9 78 12 80 10 81 9 Midazolam 12,500 Cut-off 48 42 41 49 46 44 45 45 Nitrazepam 6-Acetylmorphine Total number of Result Precision 90 44 46 95 conc.(ng/mL) Determinations +25% Cut-off 90 11 79 12 78 15 75 12 78 10 80 Norchlordiazepoxide 200 Nordiazepam 390 No drug present 40 40 negative >99% +50% Cut-off 90 0 90 0 90 0 90 0 90 0 90 Oxazepam 300 5 40 40 negative >99% 2X Cut-off 90 0 90 0 90 0 90 0 90 0 90 Temazepam 15 40 40 positive >99% 100 Triazolam 2,500 20 40 40 positive >99% Analytical Specificity

BUPRENORPHINE (BUP) BUPRENORPHINE (BUP) The following table lists the concentration of compounds (ng/mL) that were detected positive in Buprenorphine Total number of Result Precision urine by the One Step Drug of Abuse Test at a read time of 5 minutes. Buprenorphine 10 conc.(ng/mL) Determinations Norbuprenorphine 20 No drug present 60 60 negative >99% Drug Concentration (ng/ml) Codeine No reaction at 100ug/ml 5 60 60 negative >99% AMPHETAMINE (AMP 1000) Morphine No reaction at 100ug/ml 15 60 60 positive >99% d-amphetamine 1,000 20 60 60 positive >99% D,l-amphetamine 1,000 COCAINE (COC 300) l-amphetamine 20,000 Benzoylecogonine 300 PROPOXYPHENE (PPX) 1,250 Cocaethylene 300 Propoxyphene Total number of Result Precision (+/-)-Methylenedioxyamphetamine (MDA) 1,500 Cocaine 300 conc.(ng/mL) Determinations Metoclopromide 80,000 No drug present 60 60 negative >99% AMPHETAMINE (AMP 500) Procaine 75,000 150 60 60 negative >99% d-amphetamine 500 450 60 60 positive >99% D,l-amphetamine 750 COCAINE (COC 150) 600 60 60 positive >99% l-amphetamine 16,000 Benzoylecogonine 150 Phentermine 650 Cocaethylene 2,500 Analytical Sensitivity (+/-)- Methylenedioxyamphetamine (MDA) 800 Cocaine 1000 A drug-free urine pool was spiked with drugs at concentrations listed. The results are summarized below. AMPHETAMINE (AMP 300) MARIJUANA (THC 50) 9 Drug concentration AMP 1000 BAR BZO COC 300 THC 50 d-amphetamine 300 11-Nor-∆ -Tetrahydrocannabinol 50 n 9 Cut-off Range - + - + - + - + - + D,l-amphetamine 500 11-Hydroxy-∆ -Tetrahydrocannabinol 5,000 10,000 8 0% Cut-off 10 10 0 10 0 10 0 10 0 10 0 l-amphetamine 11-Nor-∆ -Tetrahydrocannabinol 50 9 P N : Phentermine 400 11-Nor-∆ -Tetrahydrocannabinol-9 Carboxylic Glucuronide 2,500 -50% Cut-off 10 10 0 10 0 10 0 10 0 10 0 500 8-Tetrahydrocannabinol Y 0 3 1 (+/-)-Methylenedioxyamphetamine (MDA) ∆ 20,000 -25% Cut-off 10 10 0 10 0 10 0 10 0 10 0 9 ∆ -Tetrahydrocannabinol 20,000 1

1 Cut-off 10 0 10 0 10 0 10 0 10 0 10 BARBITURATES (BAR) 1 0 7 3 +25% Cut-off 10 0 10 0 10 0 10 0 10 0 10 Secobarbital 300 MARIJUANA (THC 20) 9 +50% Cut-off 10 0 10 0 10 0 10 0 10 0 10 Amobarbital 300 11-nor-∆ -THC -COOH 20 Abuse Test Test was tested in duplicate using ten drug-free urine and spiked urine samples. The 11-nor-∆8-THC-COOH 50 Ethylmorphine 25,000 results demonstrate that varying ranges of urinary specific gravity do not affect the test results. cannabinol 15,000 Hydrocodone 1,580 9 EFFECT OF THE URINARY PH ∆ -THC 10,000 Hydromorphone 12,500 8 Oxymorphone 1,580 ∆ -THC 10,000 The pH of an aliquoted negative urine pool was adjusted to pH ranges of 4.0 ,4.5, 5.0, 6.0 and Thebaine 50,000 9.0, and spiked with drugs at 50% below and 50% above cut-off levels. The spiked, pH-adjusted METHADONE (MTD) urine was tested with the One Step Drug of Abuse Test. The results demonstrate that varying Methadone 300 PHENCYCLIDINE (PCP) ranges of pH do not interfere with the performance of the test. Doxylamine 50,000 Phencyclidine 25 4-Hydroxy PCP 90 CROSS-REACTIVITY METHAMPHETAMINE (mAMP 1000) PCP Morpholine 625 A study was conducted to determine the cross-reactivity of the test with compounds in either drug- (+/-)-3,4-Methylenedioxy-N-ethylamphetamine(MDEA) 20,000 free urine or drug positive urine containing Cocaine, Barbiturates, Benzodiazepines, Amphetamine, Procaine (Novocaine) 60,000 PROPOXYPHENE (PPX) Methamphetamine, Marijuana, Methadone, MDMA (Ecstasy), Opiate, Oxycodone, Phencyclidine, Norpropoxyphene 300 20,000 Morphine, EDDP (Methadone Metabolites), 6-ACM, Buprenorphine, Propoxyphene or Tricyclic Propoxyphene 300 +/-methamphetamine 1,000 Antidepressants. The following compounds show no cross-reactivity when tested with the One +methamphetamine 1,000 Step Drug of Abuse Test at concentrations of 100µg/mL. Ranitidine (Zantac) 50,000 TRICYCLIC ANTIDEPRESSANTS (TCA) NON CROSS-REACTING COMPOUNDS Methylenedioxymethamphetamine (MDMA) 2,500 Notriptyline 1,000 1,500 Cocaine, Benzodiazepines , Amphetamine , Methamphetamine , Marijuana , Opiates, METHAMPHETAMINE (mAMP 500) 12,500 Morphine, Oxycodone, Phencyclidine , Barbiturates , Buprenorphine , Propoxyphene , d-methamphetamine 500 200 EDDP, 6-Acetylmorphine. Non Cross-Reacting Compound : D,l-Methamphetamine 1,000 Doxepine 2,000 *Parent compound only lRanitidine 500,000 400 Benzylamine Acetaldehyde Berberine Procaine 200,000 2,000 Colchicine Acetaminophen Betamethasone Cortisone Methylenedioxyamphetamine (MDA) 90,000 Nordoxepine 1,000 Acetamidophenol( N-Acetyl-p-aminophenol ) Bilirubin Cortol 1,500 Methylenedioxymethamphetamine (MDMA) 2,500 Acetazolamide Brompheniramine Creatinine (+/-)-3,4-Methylenedioxy-N-ethylamphetamine(MDEA) 10,000 2,500 Acetone Bumetanide Cromolyn 3,000 Acetophenetidin Bupivacaine Cyclobenzaprine Acetopromazine METHYLENEDIOXYMETHAMPHETAMINE (MDMA) Cyclophosphamide N-Acetyl-L-cysteine Butacaine Cyclosporin A D,L-3,4-Methylenedioxymethamphetamine HCl (MDMA) 500 2-ETHYLIDENE-1,5-DIMETHYL-3,3-DIPHEYLPYRROLIDINE (EDDP) N-Acetylprocainamide (Acedainide ) Butyrophenone EDDP 300 3,4-Methylenedioxyamphetamine HCI (MDA) 3,000 Acetylsalicylic Acid ( Aspirin Caffeine Dantrolene (+/-)-3,4-Methylenedioxy-N-ethylamphetamine(MDEA) 300 Phencyclidine 50,000 Albumin, standard Camphor Deferoxamine Mesylate Disopyramide 50,000 Allobarbital (Diallybarbituric Acid ) Canrenoic Acid OPIATES (OPI 300,MOP,MOR) 100,000 Allopurinol ( 4-Hydroxypyrazole(3,4- pyrimidine ) Captopril Desipramine Carbamazepine 6-acetylmorphine 500 Tramadol 100,000 Desmethyldiazepam (Adamantan-1-amine ) Carbamyl-Carboplatin Desoximetasone Codeine 100 hydrochloride 100,000 Amcinonide Carisoprodol Dexamethasone Eserine (Physosotigmine) 15,000 Amikacin Cefaclor Dextromethorphan Ethylmorphine 100 6-ACETYLMORPHINE (6-ACM) Amiloride Cefadroxil Diazoxide Heroin 500 6-Acetylmorphine 10 p-Aminobenzoic Acid Cefotaxime Dichloromethane Hydromorphone 2,000 DL-Aminoglutethimide Cefoxitin Dichlorphenamide Amiodarone Ceftriaxone Hydrocodone 1,250 Diclofenac Amitryptyline Cefuroxime Dicyclomine Morphine 300 Ammonium Chloride Cephalexin Dieldrin Morphine-3-glucuronide 75 Cephaloridine Diflorasone Diacetate Oxycodone 75,000 Amphotericin B Cephradine Diflucortolone pivalate Thebaine 13,000 Ampicillin Chloramphenicol Diflunisal Aniline Chlorcyclizine Digitoxin Antipyrine Chloroquine OPIATES (OPI 2000) Digoxin Chlorothiazide Dihydroxymandelic Acid 6-acetylmorphine 1,000 L-Ascorbic Acid Chlorotrianisene Codeine 800 ASP-PHE-Methyl-Ester ( Aspartame) Chlorpheniramine Dimenhydrinate Ethylmorphine 400 D-Aspartic Acid Dimercaprol DL-Aspartic Acid Heroin 10,000 Chlorpropamide Dimethylaminoantipyrin L-Aspartic Acid Hydromorphone 2,000 Dimethyl Isosorbide Baclofen Chlorthalidone Dimethyl Sulfoxide Hydrocodone 5,000 Barbituric Acid Chlorzoxazone Diphenhydramine Morphine 1,600 Beclomethasone Cholesterol Dipyridamole Morphine-3-glucuronide 1,000 Beclomethasone Dipropionate Cimetidine Dipyrone Oxycodone 50,000 The following substances may interfere with the alcohol test: strong oxidizers, ascorbic acid, tannic Bendroflumethiazide Cinchonidine Benzidine Cinoxacin Thebaine 26,000 acid, polyphenolic compounds, mercaptans, uric acid, bilirubin, oxalic acid and so on, but these compounds are not normally present in sufficient amount in urine to interfere with the test. Benzilic Acid diethylaminoethyl ester Clemastine Doxycycline Benzocaine Doxylamine OXYCODONE (OXY) EFFECT OF URINARY SPECIFIC GRAVITY Benzoic Acid Clindamycin Oxycodone 100 Clobetasone Butyrate Ecgonine Codeine 50,000 Fifteen (15) urine samples of normal, high, and low specific gravity ranges (1.005, 1.015, 1.03) were Benzthiazide Clomipramine Ecgonine Methyl Ester Benztropine Dihydrocodeine 12,500 spiked with drugs at 50% below and 50% above cut-off levels respectively. The One Step Drug of Emetine Benzyl alcohol Cloxacillin ryptophan yrosine rans-2-Phenyl- riamterene rifluoperazine rimethoprim yramine emazepam etracycline etrahydrocortisone, 3 etrahydrocortisone 3 (ß-D- etrahydrozoline olbutamine Phentermine T cylopropylamine-hydrochloride ß-Phenylethlamine Prednisolone Prednisone Procaine Promethazine D,L-Propanolol D-Propoxyphene D- Quinine Ranitidine Salicylic acid Secobarbital Serotonin (5-Hydroxytyramine) Sulfamethazine Sulindac T T T Acetate T glucuronide) T Thiamine T T T T D, L-T T D, L-T Uric acid ate robam Mep hadone Met amphetamine D-meth yphenamine Methox thylene- 3,4-Me ine hylamphetam dioxyet ne- (+)3,4-Methyle hetamine dioxymethamp te Methylphenida -D-glucuronide Morphine-3-ß ate Morphine sulf Nalidixic acid Naloxone Naltrexone Naproxen Niacinamide Nifedipine Norcodein Norethindrone D-Norpropoxyphene Noscapine D,L- Oxalic acid Oxazepam Oxycodone Papaverine Penicillin-G Pentazocine Pentobarbital Phencyclidine Phenelzine Phenobarbital Ephedrine feine Y Diclofenac Diflunisal Digoxin Diphenhydramine Doxylamine Ecgonine hydrochloride Ecgonine methylester (IR,2S)-(-)-Ephedrine L-Ephedrine (-) Erythromycin ß-Estradiol Estrone-3-sulfate Ethyl-p-aminobenzoate Fenoprofen Furosemide Gentisic Hemoglobin Hydralazine Hydrochlorothiazide Hydrocodone Hydrocortisone p-Hydroxyamphetamine O-Hydroxyhippuric p-Hydroxy- methamphetamine 3-Hydroxytyramine Ibuprofen Iproniazid (-) Isoproterenol Ketoprofen Levorphanol Loperamide Meperidine e inopyrin Am al obarbit Am illin Amoxic phetamine DL-Am llin Ampici ic acid Ascorb Apomorphine Aspartame Benzilic acid Benzoic acid ine Benzoylecgon e Benzphetamin Bilirubin Brompheniramine Caf Cannabidiol Cannabinol Chloralhydrate Chloramphenicol Chlordiazepoxide Chlorothiazide (±) Chlorpheniramine Chlorpromazine Chlorquine Cholesterol Clonidine Cocaine hydrochloride Codeine Cortisone (-) Cotinine Creatinine Deoxycorticosterone Dextromethorphan Diazepam : Acid Antidepressants Non

Acid Acid Acid Acid incamine ancomycin ohimbine razodone riamcinolone riamterene riazolam richlormethiazide richloroacetic acid rifluoperazine riflupromazine rimethobenzamide rimethoprim rimipramine riprolidine ropic ropine ryptamine yramine olmetin oluene albutal amoxifen annic enoxicam erbutaline erfenadine etracycline etraethylthiuram etrahydrozoline obramycin olazamide olbutamide ricyclic T T T T T T T T T T T T T T T T T T Urea ( Carbamide ) Uric V V Y Zearalenone Zomepirac Zopiclone nine Qui nolinic Qui am Oxazep ine Ranitid namine Rescin ine Reserp Riboflavin lbuterol ) (A Salicylic Secobarbital ide Sodium Chlor ate Sodium Form e Sulfamethazin Sulfamethoxazole Sulfanilamide Sulfathiazole Sulfisoxazole Sulindac T T T T T T T T T Theobromine Theophylline Thiamine Thioridazine T T T 4-Acetamidophenol Acetophenetidin N-Acetylprocainamide Acetylsalicylic acid T Cross-Reacting Compound *Parent compound only Acid Acid Acid Acid Phenoxymethyl Penicillinic acid ( Penicillin V ) Phenylbutazone Phenylethylamine Phenylpropanolamine Phenyltoloxamine Picrotoxin Pilocarpine Pinacidil Pipecolic Pipedemic Piroxicam Potassium Chloride Potassium Iodide Prazepam Prednisone Prilocaine Primaquine Primidone Proadifen Probenecid Procainamide Procyclidine Promazine Promethazine Propionylpromazine Protriptyline Pseudoephedrine Pyridine-2-Aldoxime Pyridoxine Pyrilamine Quinidine ne enami hoxyph Met rone ogeste roxypr Hyd alin ) henidate (Rit Methylp Salicylate Methyl etone Nabum l Nadolo Nafcillin Nalidixic Nalmefene (+/-) Nicotine Nicotinic Nifedipine Nitrazepam Noscapine Oxycodone Oxymetazoline Oxyphenbutazone Oxypurinol Paclitaxel Pancuronium Bromide Papaverine Pargyline Penicillin Pentachlorophenol Pentobarbital Pentoxifylline Pentylenetetrazole p-Phenylenediamine Phenelzine Phenformin Pheniramine Phenobarbital Phenol Phenolphthalien Acid Acid Acid Acid Acid feine Imipramine Indapamide Indomethacin Ipratropium Bromide Iproniazid Isonicotinic Isopropamide Isoxsuprine Kanamycin Ketamine Ketoprofen Kynurenic Labetalol Levorphanol Loperamide Meperidine Dimethyl Sulfoxide Disopyramide Dobutamine Doxepin Doxycycline Ecgonine Ecgonine Methyl Ester Emetine Ephedrine Epinephrine Erythromycin Estriol Estrone Ethyl-p-aminobenzoate Etodolac Etoposide Famotidine Ferrous Sulfate Flufenamic Flunisolide Formaldehyde Furosemide Gemfibrozil Gentamicin Sulfate Gentisic Glucose Hemoglobin Hydralazine Hydrastine Hydrochlorothiazide Hydrocodone Hydrocortisone Hydrocarbalamine Hydroflumethiazide Hydroxyhippuric p-Hydroxyamphetamine Ibuprofen ryptine -ergoc romo-a 2-B iramine mphen Bro Caf idiol Cannab ino Cannab phenicol Chloram Chlorcyclizine ide Chlordiazepox Chloroquine Chlorothiazide ne Chlorotrianise ine Chlorpheniram e Chlorpromazin Dimercaprol Dimethylaminoantipyrin Dimethyl Isosorbide ： Aspirin) Acetazolamide Acid ( Acid Acid Acid Acid Acid Benzocaine Acid Acid incamine ancomycin ohimbine rifluoperazine riflupromazine rimethoprim rimipramine riprolidine ropic ropine ryptamine razodone riamcinolone riamterene richlormethiazide richloroacetic acid yramine nadine erfe cycline etra obramycin olazamide olbutamide olmetin oluene Methadone Non Cross-Reacting Compound *Parent compound only DL-Amphetamine sulfate DL-Aspartic L-Aspartic Apomorphine Aprobarbital Aspartame Atropine Barbituric Benzidine Benzilic Benzoic Benzoylecgonine Benzphetamine Benzthiazide Bilirubin Bisacodyl Bromazepam T T T T T T T T T Urea ( Carbamide ) Uric V V Xylometazoline Y Zearalenone Zomepirac Zopiclone Acebutolol Acetaldehyde Acetaminophen Acetone Acetophenetidin N-Acetylprocainamide (Acedainide ) Acetylsalicylic Aminopyrine Amitryptyline Ammonium Chloride Amobarbital Amoxicillin Amphotericin B Ampicillin Aniline Antipyrine T T omine Theobr ylline Theoph ne Thiami azine Thiorid T T T T T T T T T T Acid Acid Acid Acid Acid albutal annic erbutaline Sulfamethoxazole Sulfanilamide Sulfathiazole Sulfisoxazole Sulindac T T T Propionylpromazine Protriptyline Pseudoephedrine Pyridine-2-Aldoxime Pyridoxine Pyrilamine Quinidine Quinine Quinolinic Ranitidine Rescinnamine Reserpine Riboflavin Ritodrine Salbutamol (Albuterol ) Salicylic Sodium Chloride Sodium Formate Sulfamethazine Pindolol Pipecolic Pipedemic Piroxicam Potassium Chloride Potassium Iodide Prazepam Prazosin Prednisone Prilocaine Primaquine Primidone Proadifen Probenecid Procainamide Prochlorperazine Procyclidine Promazine Promethazine Pentoxifylline zole Pentylenetetra iamine p-Phenylened Phenelzine Phenformin Pheniramine Phenol en Phenolphthali Phenothiazine Phenoxymethyl ) Penicillinic acid ( Penicillin V Phentolamine Phenylbutazone Phenylethylamine Phenylpropanolamine Phenyltoloxamine Picrotoxin Pilocarpine Pimozide Pinacidil litaxel Pac mide um Bro curoni Pan rine Papave ne Pargyli in Penicill hlorophenoll Pentac Acid Acid Acid Acetic Acetic Acid Absolute Acid Acid ethylamide Acid Di Acid Acid ysergic Orphenadrine Oxalic Oxolinic Oxymetazoline Oxyphenbutazone Oxypurinol - Naphthalene Naphthol Neomycin Sulfate Niacinamide Nialamide (+/-) Nicotine Nicotinic Nifedipine Nitrofurantoin Norclomipramine Norcodeine Nordoxepin Norethindrone Norfloxacin Normorphine Noscapine Nylidrin Methoxyamine Hydroxyprogesterone Methylene Blue (Ritalin ) Methyl Salicylate Meticrane Metronidazole Milrinone Minaprine Nabumetone Nafcillin Nalbuphine Nalidixic Nalmefene Nalorphine Naloxone Naltrexone Medazepam Mefenamic Melanin Melphalan Menthol Meperidine Mephenesin Mephentermine Meprobamate Metaproterenol Methadone Methanol, Methaqualone Methazolamide Methotrimeprazine Naphthalene Naproxen e eramid Lop pam etaze Lorm L (LSD) dazole Meben ne Meclizi Meclofenamic Acid etraacetic T Acid Acid Acid Acid Acid Acid Acid Lisinopril Lithium Carbonate Levorphanol Lidocaine Kynurenic Labetalol Kanamycin Ketamine Ketoprofen Isopropamide Isoxsuprine Ipratropium Bromide Iproniazid Isonicotinic Indapamide Indomethacin Hydroxyhippuric Hydroxyzine Ibuprofen Hydrocarbalamine Hydroflumethiazide Hydrochlorothiazide Hydrocortisone Histamine DL-Homatropine Hydrastine Hexobarbital Hippuric Hemoglobin Hexachlorocyclohexane Hexachlorophene Halcinonide Guaiacol Glyceryl Ether Guanethidine Glucose Glybenclamide Griseofulvin Gentamicin Sulfate Gentisic Formaldehyde Furosemide Gemfibrozil Flurazepam Flurbiprofen Flunisolide Flurandrenolide Ferrous Sulfate Flufenamic Fenoprofen Fentanyl Etoposide Famotidine Fenfluramine Ethylenediamine Etodolac Ethopropazine mide Ethosuximide Phenylnalona Ethylene Glycol Ethamivan dard Ethanol, Stan Ethacrynic Ethambutol Estron Glucuronide fate Estrone-3-Sul al Estradi Estriol e ephrin Epin mycin Erythro Eserine PN: Y0311110703 Hydroxyprogesterone BIBLIOGRAPHY Zomepirac Hydroxyzine Ibuprofen 1. Stewart DJ, Inaba T, Lucassen M, Kalow W. Clin. Pharmacol. Ther. April 1979; 25 ed: 464, 264-8. Methylenedioxymethamphetamine Indomethacin 2. Ambre J. J. Anal. Toxicol. 1985; 9:241. Non Cross-Reacting Compound Lidocaine 3. Hawks RL, CN Chiang. Urine Testing for Drugs of Abuse. National Institute for Drug Abuse (NIDA), Research *Parent compound only: Lisinopril Lithium Monograph 73, 1986. Loperamide 4. Tietz NW. Textbook of Clinical Chemistry. W.B. Saunders Company. 1986; 1735. Acetaldehyde Lorazepam 5. FDA Guidance Document: Guidance for Premarket Submission for Kits for Screening Drugs of Abuse to be Acetaminophen Lsd Used by the Consumer, 1997. Acetazolamide Metronidazole Acetone 6. Robert DeCresce. Drug Testing in the workplace, 114. Naproxen Albumin 7. Baselt RC. Disposition of Toxic Drugs and Chemicals in Man. 2nd Ed. Biomedical Publ., Davis, CA 1982; 487. Niacinamide Albuterol 8. OSHA, The Bloodborne Pathogens Standard 29, Code of Federal Regulations 29 CFR 1910.1030. Nicotine Ammonium 9. CDC, Centers forDisease Control (CDC) Guidelines, Morbidity and Mortality Weekly Report, Volume 37, Nifedipine Amphotericin B Number 24, 1988. Nitrofurantoin Ampicillin Nortriptyline Amtriptyline Manufactured for: Ofloxacin Apomorphine Oxalic Acid Ascorbic Acid W.H.P.M., Inc. Penicillin G Aspartate 5358 Irwindale Ave. Pentobarbital Aspirin Irwindale, CA 91706 Phenobarbital www.whpm.com Prednisolone Atropine Prednisone Beclomethasone Prochloperazine Benzocaine Promethazine Benzoic Acid Propoxyphen Bilirubin Prozac (fluoxetin) Buspirone Pseudoephedrine Caffeine Pyroxidine Captopril Quinidine Carbamazepine Ranitidine Cefaclor Riboflavin Cemetidine Effective Date: 08/08/2012 Salicylic Acid Chloramphenicol Sidenafil (viagra) Chlordiazepoxide Sodium Chloride Chloroquine Sulfamethoxazole Chlorothiazide Sulindac Chlorpheniramine Temazepam Chlorpromazine Tetracycline Chlorpropamide Tetrahydrocortisone Cholesterol Theophyline Clindamycin Thiamine Clonidine Thioridazine Clozapine Thyroxine Colchicine Tobutamide Cortisone Creatinine Trimethoprim Deoxycorticosterone Tryptophan Desipramine Dextromethorphan Urea Diazepam Uric Acid Digoxin Valproic Acid Diphenhydramine Verapamil Dipyridamole Zoloft Doxycycline Erythromycin Estradiol Estriol Estrone Ethanol Ethylene Glycol Epinepherine Ferrous Sulfate Furosemide Gentamycin Glucose Haloperidol Hemoglobin Hydralazine Hydrocortisone Hydroxycarbalamine